| Value | ₹15.00 Cr |
|---|
BSE filing, NSE: AANCHALISP. Summary written from the filing by ALFA Finder's alert engine.
Aanchal Ispat Ltd: key numbers
- Share price
- ₹56.00
- Market cap
- ₹23.71 Cr
- Revenue (annual)
- ₹98.76 Cr
- Net profit (annual)
- ₹2.02 Cr
- P/E (TTM)
- 9.4×Sector 16.7×
- Promoter holding
- 50.20%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aanchal Ispat Ltd
All →Aanchal Ispat Convertible Warrants
Aanchal Ispat promoter Mukesh Goel acquired 7,26,829 fully convertible warrants at ₹82 each via preferential allotment, raising ~₹5.96 Crore. His overall stake rose to 67.37%.
- Value
- ₹5.96 Cr
Aanchal Ispat Convertible Warrants
Aanchal Ispat allotted 7,26,829 warrants at Rs 82 each to promoter Mukesh Goel, aggregating Rs 5.96 Crore. 25% upfront was received, with the balance payable on conversion.
- Value
- ₹5.96 Cr
Aanchal Ispat Other Announcement
The company has filed its quarterly shareholding pattern under SEBI Regulation 31. This is a routine compliance disclosure detailing the equity ownership structure.
Aanchal Ispat Management Change
Aanchal Ispat Limited has appointed Ms. Aparna Sharma as the Company Secretary and Compliance Officer (Key Managerial Personnel), effective October 14, 2026.
Aanchal Ispat Annual General Meeting
Aanchal Ispat Limited successfully concluded its 31st Annual General Meeting on September 23, 2026, through video conferencing to conduct routine ordinary and special business.
Aanchal Ispat Management Change
Aanchal Ispat Ltd's Company Secretary and Compliance Officer, Mr. Puspendu Kayal, has resigned effective from 5th October 2026.
Other capital structure change announcements
All →Atul Capital Structure Change
Atul bought back 4,100 equity shares on 4 November 2026 for ₹2.09 Crore. Cumulative buyback utilisation stands at ₹10.82 Crore of ₹90 Crore earmarked.
- Value
- ₹2.09 Cr
Jenburkt Pharmaceuticals Capital Structure Change
Counter Cyclical Investments Private Limited acquired 4,608 equity shares of Jenburkt Pharmaceuticals Ltd through the open market. This acquisition increased the acquirer's total holding from 5.01% to 5.11%.
Premier Explosives Capital Structure Change
Rajasthan Global Securities sold 26,53,831 shares of Premier Explosives Ltd in the open market and offer. The sale reduced the non-promoter entity's stake from 5.90% to 0.08%.
Ola Electric Mobility Capital Structure Change
Promoter and Director Bhavish Aggarwal acquired 9,81,99,966 partly paid-up equity shares of Ola Electric Mobility Ltd for ₹1,590.84 Crore. The acquisition was executed via a rights issue allotment.
- Value
- ₹159.1 Cr
Ennature Bio Pharma Capital Structure Change
Ennature Bio Pharma listed its equity shares on NSE and BSE on 4 November 2026. The company brings its API, biopolymer and nutraceutical businesses to public markets.
Identixweb Capital Structure Change
NAV Capital Emerging Star Fund, a non-promoter, bought 48,000 Identixweb shares in the open market on 2 Nov 2026, lifting its stake to 5.11%. No per-share price or total consideration is disclosed.